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etc. About one third of the arsenic in the 
atmosphere comes from natural sources, 
such as volcanoes, and the rest comes from 
anthropogenic sources (Arpan and Biswajit, 
2016; Garelick et al., 2008; WHO, 2003). 
Contamination of ground water with arsenic 
is a global problem and millions of people 
are at a risk of arsenicosis (Huang et al., 2015; 
Baig et al., 2015: Maharjan et al., 2005). 
 
Human exposure to arsenic is majorly 
ABSTRACT 
The ameliorative effect of ethanol leaf extract of Phyllantus amarus (EEPA) and vitamin C in arsenic-
induced toxicity was studied. Thirty-six (36) male albino rats divided into six groups of six (6) rats each 
were used for the study. Arsenic toxicity was induced in three of the groups by daily intake of 100 ppm 
of arsenic as Dimethylarsenate (DMA) in their drinking water.  Two of the arsenic-exposed groups 
were treated with 200 and 500 mg/kg bwt of EEPA and vitamin C respectively. The third group was not 
treated during arsenic exposure. The fourth and fifth groups were positive control for P. amarus and 
Vitamin C respectively, while another group served as the normal control. All treatments were done 
orally for six weeks. The effects of treatments on lipid profile, lipid peroxidation and liver function were 
thereafter studied. Increased levels of total cholesterol, LDL-cholesterol and malondialdehyde (MDA) 
were observed in plasma and lymphocytes of untreated arsenic-exposed rats compared to the control 
group. Arsenic increased total cholesterol and LDL-cholesterol concentrations, while triacylglycerol 
concentration was reduced significantly. Treatments with EEPA and Vitamin C however ameliorated 
the dyslipidemia observed in arsenic-exposed groups. Exposure to DMA increased plasma activities of 
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) of the animals, while plasma 
activity of ALT in rats treated with Vitamin C was not different compared to the control. Both treatments 
however, had no significant effect (p > 0.05) on the activity of plasma AST. P. amarus may therefore 
play a role in ameliorating arsenic-induced dyslipidemia in male albino rats. 
 
Keywords: Dimethylarsenate, Phyllantus amarus, vitamin C, lipid profile and liver function 
INTRODUCTION 
Arsenic is a naturally occurring chemical 
element found in abundance in the Earth’s 
crust and in small quantities in rock, soil, 
water and air. It is a metalloid which exists 
in two forms: the organic which is less toxic 
and the inorganic form which is highly toxic 
(Vahidnia et al., 2007; WHO, 2003). It is 
present in the forms of oxides or sulfides or 
as a salt of iron, sodium, calcium, copper 
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through food (Mandal, 2017; Kotz, 2011), 
water (Huang et al., 2015; WHO, 2003) and 
can sometimes be inhaled in the air through 
man-made activities like mining, burning of 
charcoal and by industrial processes (Singh 
et al., 2011). Exposure to high level of arse-
nic is reported to be associated with heart 
diseases (Monrad et al., 2017; Rasheed et al., 
2016; Chen and Karagas, 2013; Tseng et al., 
2003), cancer (Monrad et al., 2017; Smith et 
al., 1992), stroke (Rasheed et al., 2016; Chou 
et al., 2007), chronic respiratory diseases 
(Hendryx, 2009) and diabetes (Grau-Perez 
et al, 2017; Kile and Christiani, 2008). 
 
Vitamin C is a water-soluble and non-
enzymic antioxidant (Madhavi et al., 2017; 
Sirmali et al., 2014; Combs and Gerald, 
2012). When present in small amounts vita-
min C can protect indispensable molecules 
in the body, such as proteins, lipids, carbo-
hydrates and nucleic acids from damage by 
free radicals and reactive oxygen species 
(ROS) that are generated during normal me-
tabolism, by active immune cells, and 
through exposure to toxins and pollutants 
(Roy et al., 2014; Nikolic et al., 2006). Vita-
min C also participates in redox recycling of 
other important antioxidants. For example, 
it is known to regenerate vitamin E from its 
oxidized form (Traber and Stevens, 2011;  
Nikolic et al., 2006). 
 
Phyllantus amarus belongs to the Euphorbia-
ceae. It is an ethno botanical plant that is 
distributed in almost all tropical countries 
(Verma et al., 2014; Obianime and Uche, 
2009, Oluwafemi and Debiri, 2008). It pri-
marily contains lignans (Verma et al., 2014; 
Sharma et al., 1993; Somanabandhu et al., 
1993), flavonaoids (Ajibua et al., 2017; 
Umoh et al., 2013; Sharma et al., 1993) and 
tannins (Ajibua et al., 2017). P. amarus also 
contains other compounds like hydrolysable 
tannins namely phyllanthusiin D (Verma et 
al., 2014; Umoh et al., 2013; Houghton et al., 
1996), amariin (Foo, 1993) and amarulone 
(Rao and Bramley, 1971). Other components 
include amarinic acid and alkaloids like ent-
norsecurinine, sobubbialine, epibubbialine; 
diarylbutane, nyrphyllin and a neolignan, 
phyllnirurin (Ajibua et al., 2017; 
Somanabandhu et al., 1993). Phyllanthus has 
been used in Ayurvedic medicine for many 
years and has been shown to have a wide 
number of therapeutic uses. These include 
employing the whole plant for jaundice, gon-
orrhea, frequent menstruation (Verma et al., 
2014; Oluwafemi and Debiri, 2008), antimi-
crobial (Shah et al., 2017; Saranraj and Si-
vasakthivelan, 2012), anti-inflamatory 
(Adeolu and Sunday, 2013) and diabetes 
(Shetti et al., 2012; Povi et al., 2011; Cailxto et 
al., 1978). Although, Phyllanthus amarus has 
been very useful traditionally, there is no 
documented study on its use during arsenic-
osis hence this study. 
 
MATERIALS AND METHODS 
Dimethylarsenate (DMA) (trade name- Cac-
odylic acid) used was obtained from Sigma 
Chemical Company, St. Louis, MO USA. 
Vitamin C used was a product of Kunimed 
Pharmachem Ltd Lagos, Nigeria.  Other rea-
gents used were of analytical grade and were 
prepared using distilled water. 
 
Plant material and extract preparation  
Fresh leaves of Phyllantus amarus were har-
vested from Alabata village in Odeda L.G.A 
Ogun State Nigeria and authenticated by a 
Taxonomist in Federal University of Agricul-
ture, Abeokuta Ogun state Nigeria. The ex-
tract of the plant was prepared according to 
the method of Adewole et al. (2011). Fresh 
leaves of the plant were air-dried at room 
temperature and pulverized using an electric 
blender. 150 g of the ground leaves was 
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weighed and percolated in 750 ml of abso-
lute ethanol for 48 hours. The solution was 
filtered and concentrated at room tempera-
ture (25±20C) to give a yield of 4.47% (w/
w) which was later reconstituted with dis-
tilled water to obtain the required stock 
used for this experiment. 
 
Animals 
Adult male albino rats with average weight 
of 200 g obtained from the animal house of 
the Physiology Department of the Universi-
ty of Ibadan, Ibadan, Nigeria were used for 
the study. The rats were housed in cages 
maintained at 25 ± 2 0C and 12 hours light 
and dark cycle. The animals had free access 
to rat pellets and water ad-libitum. 
 
Experimental Grouping  
Adult rats were randomly divided into six 
groups of six rats each. Rats in group I 
served as the control; groups II, III and IV 
were exposed 100 ppm of arsenic as Dime-
thylarsenate (DMA) in drinking water. 
Group III and IV were treated with 200 
mg/kg body weight of the ethanolic leaf 
extract of P. amarus (EEPA) and 500 mg/kg 
body weight vitamin C respectively 
(treatment was done concurrently with arse-
nic exposure). Group V and VI were con-
trol groups for the Vitamin C and EEPA 
treatments they were given 500 mg/kg body 
weight vitamin C and 200 mg/kg body 
weight EEPA respectively. All the substanc-
es were administered orally to the animals 
for 6 weeks. 
 
Sample collection   
At the end of the treatment, animals were 
fasted overnight and sacrificed under light 
ether anaesthesia. Blood samples were col-
lected from abdominal artery into hepa-
rinized tubes while kidney and liver were 
harvested into physiological saline and then 
blotted dry.  
 
The blood samples were thereafter centri-
fuged at 4000 rpm for 5 minutes to obtain 
the plasma used for analysis. Homogenate 
(10 %) of the organs were obtained using 
0.25M sucrose for enzyme assays while chlo-
roform-methanol mixture (2:1 v/v) was used 
to obtain the homogenate used for lipid anal-
ysis.  
 
Lymphocytes isolation 
The lymphocytes were isolated using the 
method described by Skoog and Beck 
(1956). Briefly, the heparinized blood was 
mixed with Ficoll reagent in the ratio 3:2 by 
layering the blood carefully on the Ficoll so-
lution. The mixture was centrifuged for 20 
minutes at 1500 rpm at room temperature. 
The solution above the Ficoll layer contained 
the lymphocytes. Without touching the Fi-
coll layer, a sterile pipette tip was used to 
remove the lymphocytes into Eppendorf 
tubes and then stored at -20oC for further 
analysis. 
 
Lipid extraction 
Lipid extraction from animal tissues was 
done using the method described by Folch et 
al. (1957). To obtain samples used for lipid 
analysis, 0.2 mL of the isolated lymphocytes 
was mixed with 1.8 mL chloroform-
methanol (2:1) mixture while 0.2 g of liver 
and kidney was homogenized in 1.8 mL of 
chloroform-methanol (2:1) mixture. The ho-
mogenate was shaken every 5 minutes for 30 
minutes, centrifuged at 4000 rpm for 10 
minutes and the supernatant collected. 0.2 
mL of 0.05 M of KCl was then added to re-
move other non-polar components of the 
supernatant from the mixture. This was then 
mixed at room temperature for 5 minutes 
and centrifuged. The lower layer was re-
moved into dry Eppendorf tubes and was 
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used for lipid analysis.  
 
Extraction and assay of phospholipid was 
carried out by a method described by Stew-
art (1980), a method based on complex for-
mation between ammonium ferrothiocya-
nate and phospholipids. 
 
Lipid extract (0.1 mL) was evaporated to 
dryness at 60oC, cooled and 2 mL chloro-
form was added followed by 2 mL ammoni-
um ferrothiocynate. The contents were 
mixed and the phases allowed to separate. 
The chloroform layer was then removed 
and the absorbance read at 488 nm against a 
blank. 
 
HDL-cholesterol was isolated according to 
the method of Gidez et al. (1982). An aliquot 
of heparin-manganese chloride solution 
(0.025 mL) was added to 0.25 mL of plasma 
in an Eppendorf tube. The resultant mixture 
was thoroughly shaken and left to stand at 
room temperature for 10 minutes. The mix-
ture was then centrifuged at 4000 rpm for 10 
minutes. The clear supernatant obtained is 
the high density lipoproteins (HDL) fraction. 
 
Low density lipoprotein-cholesterol (LDL-cholesterol) was estimated using Friedewald  
formula:  
while the quotient TG/5 is VLDL value; TC= total cholesterol (Friedwald et al., 1972) 
Biochemical Analyses 
The activities of aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) 
were determined by colorimetric measure-
ment of hydrazone formed with 2, 4 dini-
trophenyl hydrazine as described by Reit-
man and Frankel, (1957). Total cholesterol 
and the triacylglycerol concentration were 
determined based on the methods of Allain 
(1974) and Bucolo and David, (1973) re-
spectively while the extent of lipid peroxida-
tion was estimated in terms of thiobarbitu-
ric acid reactive species (TBARS) using 
malondialdehyde (MDA) as standard by the 
method of Buege and Aust (1978). These 
parameters were determined in the plasma, 
lymphocytes and in tissue homogenates. 
Total protein was determined by Biuret 
method as described by Tietz (1995). Cu-
pric ions in an alkaline medium interact 
with protein peptides bonds. After incuba-
tion for 30 minutes at room temperature, 
absorbance of the coloured mixture is read 
against a reagent blank at 546 nm using a 
spectrophotometer. 
 
Statistical Analysis  
Values are expressed as mean ± standard 
error mean (SEM). The data were statistically 
analyzed using one way Analysis of Variance 
(ANOVA). The level of homogeneity among 
the groups was tested using Duncan’s Multi-
ple Range Test (DMRT). P values < 0.05 
were considered to be significant. 
 
RESULTS 
The levels of the total cholesterol and LDL-
cholesterol in the plasma were observed to 
be highest in the group of rats administered 
DMA only (group II) having values of 
101.66±0.96 and 45.17±0.50 mg/dL respec-
tively when compared with the control 
(group I) (78.18±1.26 mg/dL and 7.48±2.66 
mg/dL) respectively (Table 1), while triacyl-
glycerol level was significantly (p < 0.05) re-
duced in this group (Table 1). Rats adminis-
tered DMA and later given EEPA or vitamin 
C (groups III and IV) significantly had their 
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total cholesterol reduced by 36 % and 31 % 
while LDL cholesterol was reduced by 70 % 
and 88 % compared with DMA only group 
(group II) (Table 1). There was no signifi-
cant difference (p>0.05) in phospholipid 
levels in all the exposed groups when com-
pared with the control (I), although HDL-
TG and VLDL levels were significantly 
(p<0.05) lowered in the DMA only group 
(II).  
 
The values of the lipid indices observed in 
the lymphocytes were highest in the group 
administered DMA only (Table 2). Howev-
er, EEPA and Vitamin C treatments signifi-
cantly (p < 0.05) reduced the arsenic-
induced hyperlipidemia (Table 2). 
 
In DMA only (II) group, MDA concentra-
tions increased significantly (p < 0.05) in all 
the compartments studied (Table 3). How-
ever, treatment with EEPA significantly 
reduced MDA in the plasma and lympho-
cytes. Although, a reduction in MDA con-
centration was observed in the treated 
group, these values were not significant (p 
> 0.05) in the liver and kidney homoge-
nates. EEPA was observed to have a better 
ameliorative effect on the extent of lipid 
peroxidation as indicated by the concentra-
tions of MDA in the plasma and lympho-
cytes (Table 3). 
 
Table 4 shows that the animals exposed to 
100 ppm DMA only, had the highest ALT 
activity in the plasma, kidney as well as in the 
liver homogenate (7.08±0.78 U/L, 
10.13±0.92 U/mg protein, 17.34±0.64 U/
mg protein) respectively. However, the 
group exposed to DMA and then treated 
with EEPA (group III) had significantly re-
duced ALT only in the kidney homogenate 
(about 45 % reduction) while the group 
treated with vitamin C (group IV) had ALT 
values reduced significantly only in the plas-
ma (Table 4).  
 
Table 5 shows the results of the activity of 
AST in the different groups. All groups ex-
posed to DMA had increased AST activities 
in the plasma, ranging from 6.13±0.49 to 
6.67±0.48 U/I. Treatments did not have any 
effect on increased kidney AST activity ob-
served in the DMA group. Likewise in the 
liver, an AST activity of 9.92±0.79 U/mg 
protein was observed in the exposed but 
treated with EEPA (group III). 
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Table 3: Lipid peroxidation as indicated by malondialdehyde (MDA)  
                 Concentration in the animals  
Control (I) 26 ± 9.6a 18 ± 1.4a 24 ± 2.4ab 22 ± 4.7a 
Arsenic only (II) 45 ± 7.5b 35 ± 1.2b 38 ± 3.6b 39 ± 4.4b 
Arsenic +EEPA (III) 21 ± 3.8a 19 ± 0.8a 30 ± 1.4b 36 ± 3.4b 
Arsenic +Vit C (IV) 31 ± 6.4a 24 ± 1.0b 36 ± 1.4b 35 ± 3.1b 
Vit C only (V) 30 ± 1.3a 21 ± 1.3a 16 ± 2.5a 21 ± 5.7a 
EEPA only (VI) 24 ± 2.0a 19 ± 1.5a 12 ± 2.7a 22 ± 2.3a 
Values are mean ± S.E.M. Values within a column having different superscripts are  
significantly different at p < 0.05 
Table 4:Plasma, kidney, and liver alanine aminotransferase (ALT) activities in the  
              animals 
Groups n=6 Plasma (U/L) Liver (U/ mg protein) Kidney  (U/ mg 
protein) 
Control (I) 5.08 ± 0.50b 6.58 ± 1.05a 6.92 ± 1.16ab 
Arsenic only(II) 7.08 ± 0.78c 17.34 ± 0.64c 10.13 ± 0.92b 
Arsenic + EEPA (III) 6.56 ± 0.46c 15.83 ± 0.41bc 5.55 ± 0.91a 
Arsenic + vit C (IV) 5.15 ± 0.59b 12.30 ± 0.46b 7.58 ± 0.74ab 
Vit C only (V) 3.79 ± 0.54a 7.29 ± 1.40a 5.93 ± 0.46ab 
EEPA only (VI) 3.97 ± 0.47a 6.42 ± 0.67a 5.83 ± 0.67a 
Values are mean ± S.E.M. Values within a column having different superscripts are  
significantly different at p < 0.05 
Table 5: Plasma, kidney, and liver aspartate aminotransferase (AST) activities in  
               the animals 
Groups 
n=6 
Plasma 
(U/L) 
Liver 
(U/ mg protein) 
Kidney 
(U/mg protein) 
Control (I) 4.25 ± 0.49a 7.17 ± 0.31a 5.50 ± 0.59a 
Arsenic only(II) 6.67 ± 0.48b 5.00 ± 0.83a 8.25 ± 0.55b 
Arsenic + EEPA (III) 6.42 ± 0.47b 9.92 ± 0.79b            7.25 ± 4.33b 
Arsenic +Vit C (IV) 6.13 ± 0.49b 6.42 ± 0.79a 7.88 ± 0.96b 
Vit C only (V) 5.51 ± 0.40ab 7.88 ± 1.66ab 6.22 ± 0.83ab 
EEPA only (VI) 4.43 ± 0.54a 6.60 ± 0.23a 5.60 ± 1.59a 
Values are mean ± S.E.M. Values within a column having different superscripts are 
 significantly different at p < 0.05 
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DISCUSSION 
Arsenic (As) and its compounds are ubiqui-
tous in nature and exhibit both metallic and 
non-metallic properties (WHO, 2003; Ishin-
ishi et al., 1986). Reports have shown chron-
ic arsenic exposure to cause oxidative dam-
age in lymphocytes and a down regulation 
of antioxidant mechanisms (Roy et al., 2014; 
Ghosh et al., 2008). Although, arsenic has 
been reported to cause oxidative stress, 
which results in cell damage (Monrad et al., 
2017; Grau-Perez et al., 2017; Roy et al., 
2014; Vizcaya-Ruiz et al., 2009), to the best 
of our knowledge, there is no report on the 
effects of arsenic on the lipids of the lym-
phocytes. Our results showed that there was 
hypercholesterolemia, hypertriglyceridemia 
and hyperphospholipidemia with values 
(63.46 ± 3.61µg/mg protein, 49.13 ± 2.59 
µg/mg protein and 171.67 ± 5.72 µg/mg 
protein) respectively in the lymphocytes of 
the male wistar rats as a result of exposure 
to 100 ppm DMA. However, treatments 
with vitamin C and EEPA significantly 
ameliorated arsenic-induced hyperlipidemia 
in this compartment (Table 2). From our 
results, the extent of lipid peroxidation as 
indicated by the concentration of MDA in 
the animals was increased in the plasma and 
lymphocytes. Although treatment with vita-
min C and EEPA reduced the concentra-
tion of MDA in the plasma, in the lympho-
cytes only vitamin C reduced MDA concen-
tration (Table 3). This could be as a result 
of the ability of vitamin C to scavenge reac-
tive oxygen species thereby reducing this 
oxidative stress marker. Oxidative stress is 
caused by an imbalance between production 
of reactive oxygen species and biological 
system's ability to readily detoxify the reac-
tive intermediates or easily repair the result-
ing damage (Bhattacharyya et al., 2014; Reu-
ter et al, 2010; Sies, 1985). There have also 
been reports that disturbances in the nor-
mal redox state of tissues can cause toxic 
effects through the production of peroxides 
and free radicals that damage all components 
of the cell, including proteins, lipids, and 
DNA (Oluwole, 2011; James, 1994). Results 
of our study showed that exposure to arsenic 
as DMA caused oxidative stress as indicated 
by the significant increase in MDA concen-
tration in all exposed groups. 
 
Some enzymes found primarily in organs can 
also be found in low quantities in extracellu-
lar fluids. However, during tissue damage 
through leakage arising from altered permea-
bility, serum levels of such enzymes can be 
increased (Muthumani, 2013; Das et al., 2012; 
Patel and Kalia, 2010; Wills, 1985). Ami-
notranferases (ALT and AST) have been re-
ported to be markers of liver and kidney 
damage (Sangappa et al., 2017; Muthumani, 
2013; Wills, 1985). AST has been shown to 
be similar to ALT since both enzymes are 
associated with liver parenchymal cells 
(Wills, 1985). The difference is that ALT is 
found majorly in the liver, with clinically in-
significant quantities found in kidneys, heart, 
and skeletal muscle, while AST ubiquitous in 
the liver, heart (cardiac muscle), skeletal 
muscle, kidneys, brain, and red blood cells 
(Nalpas et al., 1986). ALT is therefore a more 
specific indicator of liver inflammation than 
AST, because diseases affecting these other 
organs such as myocardial infarction, acute 
pancreatitis, acute hemolytic anemia, severe 
burns, acute renal disease, musculoskeletal 
diseases, and trauma (Adil et al., 2016; Ghou-
ri et al., 2010) may cause the elevation of 
AST levels. It has been observed that biolog-
ical indicators of the hepatic damage such as 
AST and ALT showed increased activity as a 
result of arsenic exposure in drinking water 
(Milan et al., 2017; Das et al., 2012; Santra et 
al., 1999). These reports support our findings 
as shown in Tables 4 and 5. The group ad-
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ministered DMA only for six weeks (group 
II) had increased plasma activities of ALT 
(39 %) and AST (57 %). One would have 
expected a corresponding decrease in the 
renal and hepatic activities of these en-
zymes. Surprisingly, renal and hepatic ALT 
increased by 46 and 164 % respectively 
while renal AST increased by 50 % in ani-
mals exposed to DMA only (group II). Ar-
senic has been reported to inhibit both py-
ruvate dehydrogenase (PDH) and α-
ketoglutarate dehydrogenase (α-KGDH) 
complexes- enzymes found in the tricarbox-
ylic acid cycle (a pathway involved in energy 
generation (Erik et al., 2009; Navas-Acien et 
al., 2006). Inhibition of PDH and α-KGDH 
results in the accumulation of pyruvate and 
α-ketoglutarate (Schiller et al., 1977). The 
homeostatic response to this accumulation 
would be increased synthesis of AST and 
ALT to metabolize these substrates to ala-
nine and glutamate.  
 
In EEPA and Vitamin C treated groups 
(groups III and IV), activity of ALT in the 
plasma was not significantly different from 
the control (group I). This could be due to 
the antioxidant properties of both treat-
ments thus help alleviate effects of the toxi-
cant on the tissues. The importance of vita-
min C as a radical scavenger in extracellular 
fluids, trapping radicals and protecting bio-
molecules from peroxidative damages have 
been reported by Madhavi et al. (2017) and 
Sirmali et al. (2014).  
 
Phytochemical screening of P. amarus re-
vealed the presence of flavanoids, alkaloids, 
lignans and tannins thereby suggesting that 
the plant has good medicinal properties. 
The presence of flavonoids makes the plant 
a source of antioxidants which have been 
reported by Ajibua et al. (2017); Nguyen et 
al. (2017) and Lim and Murtijaya (2007). 
The presence of alkaloids and lignans also 
indicated the anti-inflammatory properties of 
the plant (Sangeeta et al., 2017). Studies have 
suggested that P. amarus has hepatoprotec-
tive, nephroprotective and cardio protective 
properties as demostated by the findings of 
Sangeeta et al. (2017), Oluwole, (2011) Lim 
and Murtijaya, (2007) and Harish and 
Shivanandappa (2006).  
 
Lipids have been reported to be one of the 
most susceptible targets of free radicals 
(Pratt et al., 2011; Rajani and Purnima, 2009). 
From our study, we observed that exposure 
to arsenic caused an oxidative change in the 
lymphocytes and plasma lipids thereby re-
sulting in dyslipidemia shown in the exposed 
groups. Epidemiological studies have associ-
ated arsenic exposure with elevated risks of 
hypertension (Wu et al., 2014; States et al., 
2009; Rahman et al., 1999; Chen et al., 1995) 
carotid atheroslecrosis (Wu et al., 2014; Wang 
et al., 2002), and ischemic heart disease 
(Hsueh, et al., 1998; Tseng et al., 2003). Based 
on the findings of this study, P. amarus and 
vitamin C may therefore play a role in the 
amelioration of arsenic-induced pathologies. 
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